Nomlabofusp program update expected mid-December to include available safety, pharmacokinetic (PK) and frataxin data, as well ...

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigational ...

U.S. Food and Drug Administration (FDA) lifted Clinical Hold on COVALENT-111 (Type 2 Diabetes) & COVALENT-112 (Type 1 Diabetes) trialsCOVALENT-111 Phase 2b 26-week topline data of the dose expansion ...